Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• JMP Securities analyst Patrick Walravens upgraded the rating for Oracle Corporation (NYSE:ORCL) from Market Perform to Market Outperform and announced a price target of $175. Oracle shares fell 1.4% to close at $139.89 on Monday. See how other analysts view this stock.
• B of A Securities analyst Andrew Obin upgraded Johnson Controls International plc (NYSE:JCI) from Neutral to Buy and boosted the price target from $76 to $80. Johnson Controls shares gained 1.1% to close at $68.60 on Monday. See how other analysts view this stock.
• Deutsche Bank analyst Derek Johnston upgraded the rating for Equity Residential (NYSE:EQR) from Hold to Buy and boosted the price target from $62 to $83. Equity Residential shares gained 1% to close at $75.10 on Monday. See how other analysts view this stock.
• JP Morgan analyst John Royall upgraded Delek US Holdings, Inc. (NYSE:DK) from Underweight to Neutral and raised the price target from $23 to $26. Delek US shares fell 3.9% to close at $18.75 on Monday. See how other analysts view this stock.
• Jefferies analyst Akash Tewari upgraded Relay Therapeutics, Inc. (NASDAQ:RLAY) from Hold to Buy and increased the price target from $10.6 to $16. Relay Therapeutics shares gained 52.4% to close at $9.51 on Monday. See how other analysts view this stock.

Considering buying JCI stock? Here's what analysts think:

Read More:

• Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone